Degrading the signal amplifier: ITK as a target for targeted protein degradation
{{output}}
In this issue of Cell Chemical Biology, Jiang and colleagues show for the first time that the Tec kinase ITK can be targeted using PROTAC approaches. This new modality has implications for the treatment of T cell lymphomas, but also potentially for the treatme... ...
